DrHouse, MD-Led Platform

DrHouse is a 24/7 on-demand telehealth platform that connects patients with licensed MDs via live video through a mobile app, with visit access available within minutes rather than days. The company''s founding premise is that primary and urgent care should be as immediate and frictionless as possible — a direct response to the days-long wait times common at many telehealth and in-person clinics. For weight loss, DrHouse physicians evaluate patients for GLP-1 medication eligibility during a standard on-demand video visit. Physicians can prescribe FDA-approved GLP-1 medications including Wegovy (semaglutide), Ozempic, Zepbound (tirzepatide), Mounjaro, and Rybelsus for eligible adults with a BMI of 30 or higher, or 27 and above with a weight-related comorbidity such as hypertension, type 2 diabetes, or sleep apnea. Prescriptions are sent electronically to the patient''s preferred pharmacy — typically on the same day as the visit. DrHouse accepts most major insurance plans, including Blue Cross Blue Shield, Aetna, UnitedHealthcare, Humana, Elevance Health (formerly Anthem), and Medicare, with typical insured copays around $25. Uninsured visits cost $129. The platform operates in all 50 states, making it one of the most geographically accessible GLP-1 prescribing options available. Unlike GLP-1-specific platforms such as Henry Meds, Mochi Health, or Noom Med, DrHouse does not offer a structured weight loss program, monthly subscription, compounded medication service, or behavioral coaching layer. Its value proposition is speed and access — patients who want to speak with a licensed physician today and have a prescription sent today will find DrHouse delivers on that promise. For ongoing GLP-1 management, dose titration, and lifestyle support, patients may want to complement a DrHouse prescription with another platform or their primary care physician. DrHouse is particularly well-positioned for patients who already understand GLP-1 medications, have done their research, and want efficient clinical access rather than a comprehensive program. It also serves as a practical option for patients in rural areas or without easy access to in-person obesity medicine, who need reliable same-day telehealth across all 50 states. response to the days-long wait times common at many telehealth and in-person clinics. For weight loss, DrHouse physicians evaluate patients for GLP-1 medication eligibility during a standard on-demand video visit. Physicians can prescribe FDA-approved GLP-1 medications including Wegovy (semaglutide), Ozempic, Zepbound (tirzepatide), Mounjaro, and Rybelsus for eligible adults with a BMI of 30 or higher, or 27 and above with a weight-related comorbidity such as hypertension, type 2 diabetes, or sleep apnea. Prescriptions are sent electronically to the patient''s preferred pharmacy — typically on the same day as the visit. DrHouse accepts most major insurance plans, including Blue Cross Blue Shield, Aetna, UnitedHealthcare, Humana, Elevance Health (formerly Anthem), and Medicare, with typical insured copays around $25. Uninsured visits cost $129. The platform operates in all 50 states, making it one of the most geographically accessible GLP-1 prescribing options available. Unlike GLP-1-specific platforms such as Henry Meds, Mochi Health, or Noom Med, DrHouse does not offer a structured weight loss program, monthly subscription, compounded medication service, or behavioral coaching layer. Its value proposition is speed and access — patients who want to speak with a licensed physician today and have a prescription sent today will find DrHouse delivers on that promise. For ongoing GLP-1 management, dose titration, and lifestyle support, patients may want to complement a DrHouse prescription with another platform or their primary care physician. DrHouse is particularly well-positioned for patients who already understand GLP-1 medications, have done their research, and want efficient clinical access rather than a comprehensive program. It also serves as a practical option for patients in rural areas or without easy access to in-person obesity medicine, who need reliable same-day telehealth across all 50 states.